子宫腺肌症类型对超长GnRH激动剂方案IVF胚胎移植临床结局的影响
本回顾性队列研究纳入首次行超长GnRH激动剂方案IVF-ET的患者,分为弥漫性腺肌症组428例、局灶性腺肌症组718例和输卵管性不孕组519例。 logistic回归显示,与局灶性腺肌症和输卵管性不孕相比,弥漫性腺肌症与临床妊娠率和活产率呈负相关,与流产呈正相关;与输卵管性不孕相比,局灶性腺肌症也是流产的危险因素。
要点
- 弥漫性腺肌症患者的临床妊娠率低于局灶性腺肌症和输卵管性不孕患者。
- 弥漫性腺肌症患者的活产率低于局灶性腺肌症和输卵管性不孕患者。
- 弥漫性腺肌症患者流产风险高于局灶性腺肌症和输卵管性不孕患者。
核心结论
- 与局灶性腺肌症或输卵管性不孕患者相比,弥漫性腺肌症患者IVF-ET的生殖结局似乎更差。
研究设计与样本
- 回顾性队列研究,纳入首次行超长GnRH激动剂方案IVF-ET的患者,分为弥漫性腺肌症组428例、局灶性腺肌症组718例和输卵管性不孕组519例。
主要发现
- 弥漫性腺肌症组与局灶性腺肌症组相比,临床妊娠的OR为0.708(95%CI 0.539至0.931,P=0.013),活产的OR为0.530(95%CI 0.385至0.730,P<0.001),流产的OR为1.727(95%CI 1.056至2.825,P=0.029)。
- 弥漫性腺肌症组与输卵管性不孕组相比,临床妊娠的OR为0.663(95%CI 0.489至0.899,P=0.008),活产的OR为0.441(95%CI 0.313至0.623,P<0.001),流产的OR为2.549(95%CI 1.278至5.082,P=0.008)。
- 局灶性腺肌症组与输卵管性不孕组相比,流产的OR为1.825(95%CI 1.112至2.995,P=0.017)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the effect of adenomyosis types on IVF and embryo transfer (IVF-ET) after ultra-long gonadotrophin-releasing hormone (GnRH) agonist protocol? DESIGN: Patients who underwent the first cycle of IVF-ET with ultra-long GnRH agonist protocol were included in this retrospective cohort study. They were divided into three groups: (A) 428 patients with diffuse adenomyosis; (B) 718 patients with focal adenomyosis; and (C) 519 patients with tubal infertility. Reproduction outcomes were analysed. RESULTS: Logistic regression analysis revealed that, compared with focal adenomyosis and tubal infertility, diffuse adenomyosis was negatively associated with clinical pregnancy and live birth (clinical pregnancy: A versus B: OR 0.708, 95% CI 0.539 to 0.931, P = 0.013; A versus C: OR 0.663, 95% CI 0.489 to 0.899, P = 0.008; live birth: A versus B: OR 0.530, 95% CI 0.385 to 0.730, P < 0.001; A versus C: OR 0.441, 95% CI 0.313 to 0.623, P < 0.001), but positively associated with miscarriage (A versus B: OR 1.727, 95% CI 1.056 to 2.825, P = 0.029; A versus C: OR 2.549, 95% CI 1.278 to 5.082, P = 0.008). Compared with patients with tubal infertility, focal adenomyosis was also a risk factor for miscarriage (B versus C: OR 1.825, 95% CI 1.112 to 2.995, P = 0.017). CONCLUSIONS: Compared with patients with focal adenomyosis or tubal infertility, the reproduction outcomes of IVF-ET in patients with diffuse adenomyosis seems to be worse.
引用
- Han B, Liang T, Zhang W, et al. The effect of adenomyosis types on clinical outcomes of IVF embryo transfer after ultra-long GnRH agonist protocol. Reprod Biomed Online. 2022. PMID: 36549997. doi:10.1016/j.rbmo.2022.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。